Advertisement
New Zealand markets closed
  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     
  • NZD/USD

    0.5895
    -0.0011 (-0.18%)
     
  • NZD/EUR

    0.5528
    -0.0016 (-0.29%)
     
  • ALL ORDS

    7,817.40
    -81.50 (-1.03%)
     
  • ASX 200

    7,567.30
    -74.80 (-0.98%)
     
  • OIL

    83.57
    +0.84 (+1.02%)
     
  • GOLD

    2,411.30
    +13.30 (+0.55%)
     
  • NASDAQ

    17,180.72
    -213.59 (-1.23%)
     
  • FTSE

    7,895.85
    +18.80 (+0.24%)
     
  • Dow Jones

    38,079.16
    +303.78 (+0.80%)
     
  • DAX

    17,737.36
    -100.04 (-0.56%)
     
  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • NZD/JPY

    91.1080
    -0.1460 (-0.16%)
     

What You Must Know About Perficient Inc’s (NASDAQ:PRFT) 6.5% ROE

This analysis is intended to introduce important early concepts to people who are starting to invest and want to start learning about core concepts of fundamental analysis on practical examples from today’s market.

Perficient Inc (NASDAQ:PRFT) generated a below-average return on equity of 6.5% in the past 12 months, while its industry returned 15.3%. An investor may attribute an inferior ROE to a relatively inefficient performance, and whilst this can often be the case, knowing the nuts and bolts of the ROE calculation may change that perspective and give you a deeper insight into PRFT’s past performance. Today I will look at how components such as financial leverage can influence ROE which may impact the sustainability of PRFT’s returns.

Check out our latest analysis for Perficient

Peeling the layers of ROE – trisecting a company’s profitability

Return on Equity (ROE) is a measure of Perficient’s profit relative to its shareholders’ equity. An ROE of 6.5% implies $0.065 returned on every $1 invested. Generally speaking, a higher ROE is preferred; however, there are other factors we must also consider before making any conclusions.

ADVERTISEMENT

Return on Equity = Net Profit ÷ Shareholders Equity

Returns are usually compared to costs to measure the efficiency of capital. Perficient’s cost of equity is 9.6%. Given a discrepancy of -3.1% between return and cost, this indicated that Perficient may be paying more for its capital than what it’s generating in return. ROE can be dissected into three distinct ratios: net profit margin, asset turnover, and financial leverage. This is called the Dupont Formula:

Dupont Formula

ROE = profit margin × asset turnover × financial leverage

ROE = (annual net profit ÷ sales) × (sales ÷ assets) × (assets ÷ shareholders’ equity)

ROE = annual net profit ÷ shareholders’ equity

NasdaqGS:PRFT Last Perf August 26th 18
NasdaqGS:PRFT Last Perf August 26th 18

Basically, profit margin measures how much of revenue trickles down into earnings which illustrates how efficient the business is with its cost management. Asset turnover reveals how much revenue can be generated from Perficient’s asset base. Finally, financial leverage will be our main focus today. It shows how much of assets are funded by equity and can show how sustainable the company’s capital structure is. Since ROE can be artificially increased through excessive borrowing, we should check Perficient’s historic debt-to-equity ratio. The debt-to-equity ratio currently stands at a low 15.0%, meaning Perficient still has headroom to borrow debt to increase profits.

NasdaqGS:PRFT Historical Debt August 26th 18
NasdaqGS:PRFT Historical Debt August 26th 18

Next Steps:

ROE is one of many ratios which meaningfully dissects financial statements, which illustrates the quality of a company. Perficient exhibits a weak ROE against its peers, as well as insufficient levels to cover its own cost of equity this year. However, ROE is not likely to be inflated by excessive debt funding, giving shareholders more conviction in the sustainability of returns, which has headroom to increase further. Although ROE can be a useful metric, it is only a small part of diligent research.

For Perficient, I’ve compiled three pertinent aspects you should further research:

  1. Financial Health: Does it have a healthy balance sheet? Take a look at our free balance sheet analysis with six simple checks on key factors like leverage and risk.

  2. Valuation: What is Perficient worth today? Is the stock undervalued, even when its growth outlook is factored into its intrinsic value? The intrinsic value infographic in our free research report helps visualize whether Perficient is currently mispriced by the market.

  3. Other High-Growth Alternatives : Are there other high-growth stocks you could be holding instead of Perficient? Explore our interactive list of stocks with large growth potential to get an idea of what else is out there you may be missing!

To help readers see past the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price-sensitive company announcements.

The author is an independent contributor and at the time of publication had no position in the stocks mentioned. For errors that warrant correction please contact the editor at editorial-team@simplywallst.com.